Cibc Private Wealth Group, LLC Standard Biotools Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 900 shares of LAB stock, worth $1,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
900
Previous 900
-0.0%
Holding current value
$1,440
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$114 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$93.8 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$27.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$24.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $126M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...